Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged greater than or equal to 75 Years: A Randomized Clinical Trial

Importance The appropriate treatment target for systolic blood pressure (SBP) in older patients with hypertension remains uncertain. Objective To evaluate the effects of intensive (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2016-06, Vol.315 (24), p.2673-2673
Hauptverfasser: Williamson, Jeff D, Supiano, Mark A, Applegate, William B, Berlowitz, Dan R, Campbell, Ruth C, Chertow, Glenn M, Fine, Larry J, Haley, William E, Hawfield, Amret T, Ix, Joachim H, Kitzman, Dalane W, Kostis, John B, Krousel-Wood, Marie A, Launer, Lenore J, Oparil, Suzanne, Rodriguez, Carlos J, Roumie, Christianne L, Shorr, Ronald I, Sink, Kaycee M, Wadley, Virginia G, Whelton, Paul K, Whittle, Jeffrey, Woolard, Nancy F, Wright, Jackson T, Pajewski, Nicholas M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2673
container_issue 24
container_start_page 2673
container_title JAMA : the journal of the American Medical Association
container_volume 315
creator Williamson, Jeff D
Supiano, Mark A
Applegate, William B
Berlowitz, Dan R
Campbell, Ruth C
Chertow, Glenn M
Fine, Larry J
Haley, William E
Hawfield, Amret T
Ix, Joachim H
Kitzman, Dalane W
Kostis, John B
Krousel-Wood, Marie A
Launer, Lenore J
Oparil, Suzanne
Rodriguez, Carlos J
Roumie, Christianne L
Shorr, Ronald I
Sink, Kaycee M
Wadley, Virginia G
Whelton, Paul K
Whittle, Jeffrey
Woolard, Nancy F
Wright, Jackson T
Pajewski, Nicholas M
description Importance The appropriate treatment target for systolic blood pressure (SBP) in older patients with hypertension remains uncertain. Objective To evaluate the effects of intensive (
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1811906641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1811906641</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_18119066413</originalsourceid><addsrcrecordid>eNqVjLtOw0AQRV2ARHj8wy1pItmKiR06Y0BQgSANVTSyh7BovUNmdl3wMXwrW_AD3OYU5-geFYuy3LTLpm7rk-LU7LPMq1bNovh5DJGDuZkxG14jhZF0xI0XGfGsbJaU0UuIKh7Zos_eyUw2JE-KW2dMxnhKcZCJDS6gG5OPhm7PI_bKFFkRPyhAFHxI5BEFzRXemNSu0eElH8vkvnPfexfckJOtOvLnxfE7eeOLP54Vl_d32_5h-aVySGxxNzkb2HsKLMl2VVtVm3K9rqvVP9Jfki1d8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1811906641</pqid></control><display><type>article</type><title>Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged greater than or equal to 75 Years: A Randomized Clinical Trial</title><source>American Medical Association Journals</source><creator>Williamson, Jeff D ; Supiano, Mark A ; Applegate, William B ; Berlowitz, Dan R ; Campbell, Ruth C ; Chertow, Glenn M ; Fine, Larry J ; Haley, William E ; Hawfield, Amret T ; Ix, Joachim H ; Kitzman, Dalane W ; Kostis, John B ; Krousel-Wood, Marie A ; Launer, Lenore J ; Oparil, Suzanne ; Rodriguez, Carlos J ; Roumie, Christianne L ; Shorr, Ronald I ; Sink, Kaycee M ; Wadley, Virginia G ; Whelton, Paul K ; Whittle, Jeffrey ; Woolard, Nancy F ; Wright, Jackson T ; Pajewski, Nicholas M</creator><creatorcontrib>Williamson, Jeff D ; Supiano, Mark A ; Applegate, William B ; Berlowitz, Dan R ; Campbell, Ruth C ; Chertow, Glenn M ; Fine, Larry J ; Haley, William E ; Hawfield, Amret T ; Ix, Joachim H ; Kitzman, Dalane W ; Kostis, John B ; Krousel-Wood, Marie A ; Launer, Lenore J ; Oparil, Suzanne ; Rodriguez, Carlos J ; Roumie, Christianne L ; Shorr, Ronald I ; Sink, Kaycee M ; Wadley, Virginia G ; Whelton, Paul K ; Whittle, Jeffrey ; Woolard, Nancy F ; Wright, Jackson T ; Pajewski, Nicholas M</creatorcontrib><description>Importance The appropriate treatment target for systolic blood pressure (SBP) in older patients with hypertension remains uncertain. Objective To evaluate the effects of intensive (&lt;120 mm Hg) compared with standard (&lt;140 mm Hg) SBP targets in persons aged 75 years or older with hypertension but without diabetes. Design, Setting, and Participants A multicenter, randomized clinical trial of patients aged 75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT). Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015. Interventions Participants were randomized to an SBP target of less than 120 mm Hg (intensive treatment group, n = 1317) or an SBP target of less than 140 mm Hg (standard treatment group, n =1319). Main Outcomes and Measures The primary cardiovascular disease outcome was a composite of nonfatal myocardial infarction, acute coronary syndrome not resulting in a myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death from cardiovascular causes. All-cause mortality was a secondary outcome. Results Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%) provided complete follow-up data. At a median follow-up of 3.14 years, there was a significantly lower rate of the primary composite outcome (102 events in the intensive treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66 [95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67 [95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI, 0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs 2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for injurious falls (HR, 0.91 [95% CI, 0.65-1.29]). Conclusions and Relevance Among ambulatory adults aged 75 years or older, treating to an SBP target of less than 120 mm Hg compared with an SBP target of less than 140 mm Hg resulted in significantly lower rates of fatal and nonfatal major cardiovascular events and death from any cause.</description><identifier>ISSN: 0098-7484</identifier><language>eng</language><ispartof>JAMA : the journal of the American Medical Association, 2016-06, Vol.315 (24), p.2673-2673</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids></links><search><creatorcontrib>Williamson, Jeff D</creatorcontrib><creatorcontrib>Supiano, Mark A</creatorcontrib><creatorcontrib>Applegate, William B</creatorcontrib><creatorcontrib>Berlowitz, Dan R</creatorcontrib><creatorcontrib>Campbell, Ruth C</creatorcontrib><creatorcontrib>Chertow, Glenn M</creatorcontrib><creatorcontrib>Fine, Larry J</creatorcontrib><creatorcontrib>Haley, William E</creatorcontrib><creatorcontrib>Hawfield, Amret T</creatorcontrib><creatorcontrib>Ix, Joachim H</creatorcontrib><creatorcontrib>Kitzman, Dalane W</creatorcontrib><creatorcontrib>Kostis, John B</creatorcontrib><creatorcontrib>Krousel-Wood, Marie A</creatorcontrib><creatorcontrib>Launer, Lenore J</creatorcontrib><creatorcontrib>Oparil, Suzanne</creatorcontrib><creatorcontrib>Rodriguez, Carlos J</creatorcontrib><creatorcontrib>Roumie, Christianne L</creatorcontrib><creatorcontrib>Shorr, Ronald I</creatorcontrib><creatorcontrib>Sink, Kaycee M</creatorcontrib><creatorcontrib>Wadley, Virginia G</creatorcontrib><creatorcontrib>Whelton, Paul K</creatorcontrib><creatorcontrib>Whittle, Jeffrey</creatorcontrib><creatorcontrib>Woolard, Nancy F</creatorcontrib><creatorcontrib>Wright, Jackson T</creatorcontrib><creatorcontrib>Pajewski, Nicholas M</creatorcontrib><title>Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged greater than or equal to 75 Years: A Randomized Clinical Trial</title><title>JAMA : the journal of the American Medical Association</title><description>Importance The appropriate treatment target for systolic blood pressure (SBP) in older patients with hypertension remains uncertain. Objective To evaluate the effects of intensive (&lt;120 mm Hg) compared with standard (&lt;140 mm Hg) SBP targets in persons aged 75 years or older with hypertension but without diabetes. Design, Setting, and Participants A multicenter, randomized clinical trial of patients aged 75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT). Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015. Interventions Participants were randomized to an SBP target of less than 120 mm Hg (intensive treatment group, n = 1317) or an SBP target of less than 140 mm Hg (standard treatment group, n =1319). Main Outcomes and Measures The primary cardiovascular disease outcome was a composite of nonfatal myocardial infarction, acute coronary syndrome not resulting in a myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death from cardiovascular causes. All-cause mortality was a secondary outcome. Results Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%) provided complete follow-up data. At a median follow-up of 3.14 years, there was a significantly lower rate of the primary composite outcome (102 events in the intensive treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66 [95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67 [95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI, 0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs 2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for injurious falls (HR, 0.91 [95% CI, 0.65-1.29]). Conclusions and Relevance Among ambulatory adults aged 75 years or older, treating to an SBP target of less than 120 mm Hg compared with an SBP target of less than 140 mm Hg resulted in significantly lower rates of fatal and nonfatal major cardiovascular events and death from any cause.</description><issn>0098-7484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqVjLtOw0AQRV2ARHj8wy1pItmKiR06Y0BQgSANVTSyh7BovUNmdl3wMXwrW_AD3OYU5-geFYuy3LTLpm7rk-LU7LPMq1bNovh5DJGDuZkxG14jhZF0xI0XGfGsbJaU0UuIKh7Zos_eyUw2JE-KW2dMxnhKcZCJDS6gG5OPhm7PI_bKFFkRPyhAFHxI5BEFzRXemNSu0eElH8vkvnPfexfckJOtOvLnxfE7eeOLP54Vl_d32_5h-aVySGxxNzkb2HsKLMl2VVtVm3K9rqvVP9Jfki1d8w</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Williamson, Jeff D</creator><creator>Supiano, Mark A</creator><creator>Applegate, William B</creator><creator>Berlowitz, Dan R</creator><creator>Campbell, Ruth C</creator><creator>Chertow, Glenn M</creator><creator>Fine, Larry J</creator><creator>Haley, William E</creator><creator>Hawfield, Amret T</creator><creator>Ix, Joachim H</creator><creator>Kitzman, Dalane W</creator><creator>Kostis, John B</creator><creator>Krousel-Wood, Marie A</creator><creator>Launer, Lenore J</creator><creator>Oparil, Suzanne</creator><creator>Rodriguez, Carlos J</creator><creator>Roumie, Christianne L</creator><creator>Shorr, Ronald I</creator><creator>Sink, Kaycee M</creator><creator>Wadley, Virginia G</creator><creator>Whelton, Paul K</creator><creator>Whittle, Jeffrey</creator><creator>Woolard, Nancy F</creator><creator>Wright, Jackson T</creator><creator>Pajewski, Nicholas M</creator><scope>7TS</scope></search><sort><creationdate>20160601</creationdate><title>Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged greater than or equal to 75 Years: A Randomized Clinical Trial</title><author>Williamson, Jeff D ; Supiano, Mark A ; Applegate, William B ; Berlowitz, Dan R ; Campbell, Ruth C ; Chertow, Glenn M ; Fine, Larry J ; Haley, William E ; Hawfield, Amret T ; Ix, Joachim H ; Kitzman, Dalane W ; Kostis, John B ; Krousel-Wood, Marie A ; Launer, Lenore J ; Oparil, Suzanne ; Rodriguez, Carlos J ; Roumie, Christianne L ; Shorr, Ronald I ; Sink, Kaycee M ; Wadley, Virginia G ; Whelton, Paul K ; Whittle, Jeffrey ; Woolard, Nancy F ; Wright, Jackson T ; Pajewski, Nicholas M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_18119066413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williamson, Jeff D</creatorcontrib><creatorcontrib>Supiano, Mark A</creatorcontrib><creatorcontrib>Applegate, William B</creatorcontrib><creatorcontrib>Berlowitz, Dan R</creatorcontrib><creatorcontrib>Campbell, Ruth C</creatorcontrib><creatorcontrib>Chertow, Glenn M</creatorcontrib><creatorcontrib>Fine, Larry J</creatorcontrib><creatorcontrib>Haley, William E</creatorcontrib><creatorcontrib>Hawfield, Amret T</creatorcontrib><creatorcontrib>Ix, Joachim H</creatorcontrib><creatorcontrib>Kitzman, Dalane W</creatorcontrib><creatorcontrib>Kostis, John B</creatorcontrib><creatorcontrib>Krousel-Wood, Marie A</creatorcontrib><creatorcontrib>Launer, Lenore J</creatorcontrib><creatorcontrib>Oparil, Suzanne</creatorcontrib><creatorcontrib>Rodriguez, Carlos J</creatorcontrib><creatorcontrib>Roumie, Christianne L</creatorcontrib><creatorcontrib>Shorr, Ronald I</creatorcontrib><creatorcontrib>Sink, Kaycee M</creatorcontrib><creatorcontrib>Wadley, Virginia G</creatorcontrib><creatorcontrib>Whelton, Paul K</creatorcontrib><creatorcontrib>Whittle, Jeffrey</creatorcontrib><creatorcontrib>Woolard, Nancy F</creatorcontrib><creatorcontrib>Wright, Jackson T</creatorcontrib><creatorcontrib>Pajewski, Nicholas M</creatorcontrib><collection>Physical Education Index</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williamson, Jeff D</au><au>Supiano, Mark A</au><au>Applegate, William B</au><au>Berlowitz, Dan R</au><au>Campbell, Ruth C</au><au>Chertow, Glenn M</au><au>Fine, Larry J</au><au>Haley, William E</au><au>Hawfield, Amret T</au><au>Ix, Joachim H</au><au>Kitzman, Dalane W</au><au>Kostis, John B</au><au>Krousel-Wood, Marie A</au><au>Launer, Lenore J</au><au>Oparil, Suzanne</au><au>Rodriguez, Carlos J</au><au>Roumie, Christianne L</au><au>Shorr, Ronald I</au><au>Sink, Kaycee M</au><au>Wadley, Virginia G</au><au>Whelton, Paul K</au><au>Whittle, Jeffrey</au><au>Woolard, Nancy F</au><au>Wright, Jackson T</au><au>Pajewski, Nicholas M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged greater than or equal to 75 Years: A Randomized Clinical Trial</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><date>2016-06-01</date><risdate>2016</risdate><volume>315</volume><issue>24</issue><spage>2673</spage><epage>2673</epage><pages>2673-2673</pages><issn>0098-7484</issn><abstract>Importance The appropriate treatment target for systolic blood pressure (SBP) in older patients with hypertension remains uncertain. Objective To evaluate the effects of intensive (&lt;120 mm Hg) compared with standard (&lt;140 mm Hg) SBP targets in persons aged 75 years or older with hypertension but without diabetes. Design, Setting, and Participants A multicenter, randomized clinical trial of patients aged 75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT). Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015. Interventions Participants were randomized to an SBP target of less than 120 mm Hg (intensive treatment group, n = 1317) or an SBP target of less than 140 mm Hg (standard treatment group, n =1319). Main Outcomes and Measures The primary cardiovascular disease outcome was a composite of nonfatal myocardial infarction, acute coronary syndrome not resulting in a myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death from cardiovascular causes. All-cause mortality was a secondary outcome. Results Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%) provided complete follow-up data. At a median follow-up of 3.14 years, there was a significantly lower rate of the primary composite outcome (102 events in the intensive treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66 [95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67 [95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI, 0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs 2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for injurious falls (HR, 0.91 [95% CI, 0.65-1.29]). Conclusions and Relevance Among ambulatory adults aged 75 years or older, treating to an SBP target of less than 120 mm Hg compared with an SBP target of less than 140 mm Hg resulted in significantly lower rates of fatal and nonfatal major cardiovascular events and death from any cause.</abstract></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2016-06, Vol.315 (24), p.2673-2673
issn 0098-7484
language eng
recordid cdi_proquest_miscellaneous_1811906641
source American Medical Association Journals
title Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged greater than or equal to 75 Years: A Randomized Clinical Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T04%3A05%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intensive%20vs%20Standard%20Blood%20Pressure%20Control%20and%20Cardiovascular%20Disease%20Outcomes%20in%20Adults%20Aged%20greater%20than%20or%20equal%20to%2075%20Years:%20A%20Randomized%20Clinical%20Trial&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Williamson,%20Jeff%20D&rft.date=2016-06-01&rft.volume=315&rft.issue=24&rft.spage=2673&rft.epage=2673&rft.pages=2673-2673&rft.issn=0098-7484&rft_id=info:doi/&rft_dat=%3Cproquest%3E1811906641%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1811906641&rft_id=info:pmid/&rfr_iscdi=true